Blood News and Research

RSS

Mayo Clinic uses Arctic Front Cardiac CryoAblation Catheter system for treating AF

Mayo Clinic is the first in the U.S. to use the first minimally invasive freezing balloon technology for the treatment of atrial fibrillation approved in December by the U.S. Food and Drug Administration. The first patient received the treatment Tuesday, Jan. 4.

6 Jan 2011

Scientists identify prognostic biomarker to treat patients with HCV

Scientists at Inserm and Institut Pasteur have performed biomarker discovery on patients being treated for chronic hepatitis C infection. Their work, published in The Journal of Clinical Investigation, demonstrates that the plasma levels of the protein IP-10 predict, prior to treatment initiation, the efficacy of treatment with pegylated-interferon and ribavirin.

6 Jan 2011

Columbia research team identifies bacteria may play a key role in atherosclerosis

Dr. Emil Kozarov and a team of researchers at the Columbia University College of Dental Medicine have identified specific bacteria that may have a key role in vascular pathogenesis, specifically atherosclerosis, or what is commonly referred to as "hardening of the arteries" - the number one cause of death in the United States.

6 Jan 2011

IV fluids for trauma patients may not be life savers all the time

Severely injured patients who are routinely given IV fluids by paramedics before transport to the nearest trauma center are significantly more likely to die than similarly injured patients who don't get the time-consuming IV treatment before hospitalization, new Johns Hopkins-led research suggests.

6 Jan 2011

Cardiologists identify blood protein fragment that can predict heart attack

Cardiologists at the University of Connecticut Health Center have identified a protein fragment that when detected in the blood can be a predictor of heart attack.

6 Jan 2011

Study provides new insights into how viruses establish chronic infections

Walter and Eliza Hall Institute researchers in Melbourne, Australia, have discovered how a key viral gene helps viruses evade early detection by the immune system. Their finding is providing new insights into how viruses are able to establish chronic infections, leading scientists to reevaluate their approaches to viral vaccine development.

6 Jan 2011

Breakthrough in MRI allows brain scans more than seven times faster

An international team of physicists and neuroscientists has reported a breakthrough in magnetic resonance imaging that allows brain scans more than seven times faster than currently possible.

6 Jan 2011

Omeros receives exclusive license for new series of antifibrinolytic agents

Omeros Corporation (Nasdaq: OMER) today announced that it has obtained an exclusive license from The Regents of the University of California to a new series of antifibrinolytic agents. These optimized agents represent a significant potential advance in the control of surgical and traumatic bleeding.

6 Jan 2011

Students donate $6.1 million for cancer research

Students donated a record $6.1 million during Olive Garden's Pasta for Pennies program last year to bring the total amount collected since the program's inception to more than $53 million.

6 Jan 2011

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

Ikaria, Inc. today announced that the U.S. Food and Drug Administration has granted INOMAX for inhalation an additional six months of marketing exclusivity, known as "pediatric exclusivity."

6 Jan 2011

Researchers investigate umbilical cord blood stem cells for traumatic brain injury in children

The University of Texas Health Science Center at Houston has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children.

6 Jan 2011

DJO Incorporated announces acquisition of Elastic Therapy

DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced the acquisition of Elastic Therapy, Inc. The acquisition closed yesterday, January 4, 2011.

6 Jan 2011

EDMA to endorse the campaign on Hypoparathyroidism

On the occasion of the World Hypoparathyroidism Awareness Day 2011, EDMA, the European Diagnostic Manufacturers Association, highlights the crucial role the In Vitro Diagnostic (IVD) industry can play to effectively testing this rare endocrine condition.

5 Jan 2011

New resolvin reduces levels of pro-inflammatory molecules and cells in inflammation caused by E. coli

Inflammation is a protective response to invading microbes and tissue damage. Upon microbe clearance from the body or completion of wound healing, the inflammatory response must be dampened down.

5 Jan 2011

UC professor receives Fulbright Scholar Award to explore health education efforts in China

The New Year has a University of Cincinnati professor sharing his vast and vital research background on health education in a new location. Randall Cottrell, a UC professor of health promotion and education in the College of Education, Criminal Justice, and Human Services (CECH), is spending the winter and spring academic quarters at Zhejiang University in Hangzhou, China.

5 Jan 2011

ImmunGene, Cephalon Australia collaborate to advance new class of protein therapeutics

ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.

5 Jan 2011

Unique vaccine produces long-lasting anti-cocaine immunity in mice

Researchers from The Scripps Research Institute, Weill Cornell Medical College, and Cornell University have produced a long-lasting anti-cocaine immunity in mice by giving them a unique vaccine that combines bits of the common cold virus with a particle that mimics cocaine.

5 Jan 2011

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Celgene International Sàrl announced regulatory submissions for its blood cancer therapies REVLIMID (lenalidomide) and ISTODAX (romidepsin).

5 Jan 2011

Betulin in birch bark appears to provide metabolic benefits

An ingredient found in abundance in birch bark appears to have an array of metabolic benefits, according to new studies in animals that are reported in the January issue of Cell Metabolism, a Cell Press publication.

5 Jan 2011

Insecticidal nets do not always work against diseases transmitted by insect bites

Longlasting insecticidal nets yielded an important breakthrough in malaria prevention, but this does not automatically mean they always work against diseases transmitted by insect bites. Against the transmission of kala azar disease in India and Nepal they did not have an effect. This was reported by an international group of researchers, led by Marleen Boelaert of the Institute of Tropical Medicine Antwerp, in the reputed British Medical Journal.

5 Jan 2011

Blood News and Research

Mayo Clinic uses Arctic Front Cardiac CryoAblation Catheter system for treating AF

Scientists identify prognostic biomarker to treat patients with HCV

Columbia research team identifies bacteria may play a key role in atherosclerosis

IV fluids for trauma patients may not be life savers all the time

Cardiologists identify blood protein fragment that can predict heart attack

Study provides new insights into how viruses establish chronic infections

Breakthrough in MRI allows brain scans more than seven times faster

Omeros receives exclusive license for new series of antifibrinolytic agents

Students donate $6.1 million for cancer research

FDA grants additional marketing exclusivity to INOMAX for pediatric BPD treatment

Researchers investigate umbilical cord blood stem cells for traumatic brain injury in children

DJO Incorporated announces acquisition of Elastic Therapy

EDMA to endorse the campaign on Hypoparathyroidism

New resolvin reduces levels of pro-inflammatory molecules and cells in inflammation caused by E. coli

UC professor receives Fulbright Scholar Award to explore health education efforts in China

ImmunGene, Cephalon Australia collaborate to advance new class of protein therapeutics

Unique vaccine produces long-lasting anti-cocaine immunity in mice

Celgene announces regulatory submissions for blood cancer therapies REVLIMID and ISTODAX

Betulin in birch bark appears to provide metabolic benefits

Insecticidal nets do not always work against diseases transmitted by insect bites

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News